4.6 Article

A Synthetic Antibody Fragment Targeting Nicastrin Affects Assembly and Trafficking of γ-Secretase

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 50, Pages 34851-34861

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M114.609636

Keywords

Alzheimer Disease; Amyloid Precursor Protein (APP); Cancer; -Secretase; Notch Receptor; Synthetic Antibody

Funding

  1. National Institutes of Health [P30 NS061777, S10 RR022415, U01 NS074501, R01AG026660, U54-GM087519, R01-GM072688]
  2. Adler Foundation
  3. Edward H. Levy Fund
  4. Alzheimer's Association
  5. American Health Assistance Foundation
  6. Cure Alzheimer's Fund
  7. University of Chicago Comprehensive Cancer Center
  8. Eisai Research Labs Inc.
  9. AZ Therapies Inc.
  10. Jannsen Pharmaceutica NV

Ask authors/readers for more resources

Background: -Secretase is critical in Notch signaling and Alzheimer disease. Results: Coexpression of a nicastrin antibody affects maturation and trafficking of -secretase and alters Notch and APP processing. Conclusion: Nicastrin is a feasible target for modulating the targeting and substrate specificity of -secretase. Significance: Modulation of -secretase through nicastrin may be of therapeutic value in cancer and Alzheimer disease. The -secretase complex, composed of presenilin, nicastrin (NCT), anterior pharynx-defective 1 (APH-1), and presenilin enhancer 2 (PEN-2), is assembled in a highly regulated manner and catalyzes the intramembranous proteolysis of many type I membrane proteins, including Notch and amyloid precursor protein. The Notch family of receptors plays important roles in cell fate specification during development and in adult tissues, and aberrant hyperactive Notch signaling causes some forms of cancer. -Secretase-mediated processing of Notch at the cell surface results in the generation of the Notch intracellular domain, which associates with several transcriptional coactivators involved in nuclear signaling events. On the other hand, -secretase-mediated processing of amyloid precursor protein leads to the production of amyloid (A) peptides that play an important role in the pathogenesis of Alzheimer disease. We used a phage display approach to identify synthetic antibodies that specifically target NCT and expressed them in the single-chain variable fragment (scFv) format in mammalian cells. We show that expression of a NCT-specific scFv clone, G9, in HEK293 cells decreased the production of the Notch intracellular domain but not the production of amyloid peptides that occurs in endosomal and recycling compartments. Biochemical studies revealed that scFvG9 impairs the maturation of NCT by associating with immature forms of NCT and, consequently, prevents its association with the other components of the -secretase complex, leading to degradation of these molecules. The reduced cell surface levels of mature -secretase complexes, in turn, compromise the intramembranous processing of Notch.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available